Hacker Newsnew | past | comments | ask | show | jobs | submitlogin

Having a time limited monopoly on new drugs seems required considering the costs involved in getting drugs through the regulatory framework.


Considering how much more is spent on marketing and executive salaries, maybe we don't?

Or the patent protection is contingent on limits to marketing and admin overhead




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: